The Experts below are selected from a list of 312 Experts worldwide ranked by ideXlab platform
Inderbir S. Gill - One of the best experts on this subject based on the ideXlab platform.
-
Robotic renal and Adrenal Surgery.
The Surgical clinics of North America, 2003Co-Authors: Gyung Tak Sung, Inderbir S. GillAbstract:Incorporation of robotic enhancement technology (RET) with advanced telecommunication technologies has the potential to alleviate certain inherent technical limitations of pure laparoscopic Surgery, such as 2-D vision, ergonomic limitations, and image reversal; however, there remain areas that need to be further improved and evaluated before clinical application in Adrenal and kidney procedures in urology. Herein, after a brief review of surgical robotic devices, we discuss recent advances in robotic research and emerging clinical applications, and the future potential of robotics in urology.
-
robotic assisted laparoscopic Adrenalectomy
Urology, 2002Co-Authors: Mihir M Desai, Gyung Tak Sung, Inderbir S. Gill, Jihad H Kaouk, Surena F Matin, Emmanuel L BravoAbstract:The laparoscopic technology has presented new frontiers to Adrenal Surgery thus enabling modification and refinement of established conventional procedures. The integration of robots into Adrenal Surgery has made it feasible to offer alternatives to patients requiring surgical treatment of Adrenal disorders. The robotic assistance may allow more surgeons, with limited conventional laparoscopic experience to offer to their patients a mini invasive approach.
-
the case for laparoscopic Adrenalectomy
The Journal of Urology, 2001Co-Authors: Inderbir S. GillAbstract:Purpose: The current status of laparoscopic Adrenal Surgery was assessed.Materials and Methods: A current MEDLINE search revealed 308 articles pertaining to laparoscopic Surgery of the Adrenal gland. Based on this literature review laparoscopic surgical anatomy, current indications and contraindications, and laparoscopic techniques were identified. The role of laparoscopic Surgery for various Adrenal disorders, including aldosteroma, pheochromocytoma, Cushing’s syndrome, incidentaloma and Adrenal cancer, were evaluated. Studies specifically comparing open versus laparoscopic Adrenalectomy and the financial implications of laparoscopy were evaluated. Furthermore, newer advances in the minimally invasive management of surgical Adrenal disease were identified.Results: Available data from multiple institutions imply that laparoscopic Adrenal Surgery is safe and efficacious for aldosteroma, pheochromocytoma, Cushing’s disease and incidentaloma. Compared to open Surgery laparoscopy provides equally effective tr...
-
laparoscopic renal and Adrenal Surgery in obese patients comparison to open Surgery
The Journal of Urology, 1999Co-Authors: Surena Fazelimatin, Gyung Tak Sung, Inderbir S. Gill, Thomas H S Hsu, Andrew C NovickAbstract:AbstractPurpose: The efficacy and morbidity of laparoscopic renal and Adrenal Surgery in comparison to open Surgery in obese patients are unknown. This retrospective study was performed to compare the outcome of laparoscopic versus open renal and Adrenal Surgery in the markedly and morbidly obese patient (body mass index 30 or greater).Materials and Methods: The study group comprised all obese patients undergoing laparoscopic renal and Adrenal Surgery (laparoscopic group) from August 1997 to February 1998 at our institution. The majority of procedures were performed using a retroperitoneoscopic approach via the flank. These patients were compared with all obese patients undergoing open renal and Adrenal Surgery (open group) from 1994 to 1998. Open group patients with factors precluding laparoscopic Surgery were excluded from the study (mass greater than 10 cm., renal vein and/or inferior vena caval thrombus and extension outside Gerota's fascia).Results: There were 21 obese patients in each group and base...
Akshay Sood - One of the best experts on this subject based on the ideXlab platform.
-
adverse event rates timing of complications and the impact of specialty on outcomes following Adrenal Surgery an analysis of 30 day outcome data from the american college of surgeons national surgical quality improvement program acs nsqip
Urology, 2016Co-Authors: Akshay Sood, Kaustav Majumder, Naveen Kachroo, Jesse D Sammon, Firas Abdollah, Marianne Schmid, Linda Hsu, Wooju JeongAbstract:Objective To report on 30-day adverse event rates and timing of complications following Adrenal Surgery; further, to investigate the impact of specialty (general Surgery vs urology) on these outcomes using a large prospective multi-institutional data registry. Materials and Methods Within the American College of Surgeons National Surgical Quality Improvement Program (2005-2012), patients undergoing Adrenalectomy were identified (CPT-codes: 60540, 60545, 60650). Outcomes evaluated included complications, blood transfusion, length of stay, reintervention, readmission, and mortality. Complications were further evaluated in relation to discharge status (pre-/postdischarge). Multivariable regression models assessed association between specialty and 30-day morbidity/mortality. Results During the study period, 4844 patients underwent Adrenalectomy (95.7% general Surgery). The overall complication rate was 7.5% (n = 363); 43.2% of the complications occurred postdischarge with a substantial proportion of major complications, including cardiac, pulmonary, renal, neurologic, septic, and deep venous thrombosis/pulmonary embolism also occurring postdischarge (29.9%). The overall blood transfusion, reintervention, readmission, and mortality rates were 3.9%, 2.0%, 6.4%, and 0.6%, respectively. In adjusted analyses, specialty did not have an effect on any of the outcomes ( P > .05 all). Conclusion One in 13 patients suffers a complication postAdrenalectomy. Approximately 40% of these complications occur postdischarge, primarily within the first 2 weeks of Surgery. Accurate knowledge regarding 30-day adverse event rates and timing of complications that this study provides may facilitate improved patient-physician communication and encourage early patient follow-up in this critical window. Lastly, specialty does not seem to affect outcomes in American College of Surgeons National Surgical Quality Improvement Program participant hospitals.
Wooju Jeong - One of the best experts on this subject based on the ideXlab platform.
-
adverse event rates timing of complications and the impact of specialty on outcomes following Adrenal Surgery an analysis of 30 day outcome data from the american college of surgeons national surgical quality improvement program acs nsqip
Urology, 2016Co-Authors: Akshay Sood, Kaustav Majumder, Naveen Kachroo, Jesse D Sammon, Firas Abdollah, Marianne Schmid, Linda Hsu, Wooju JeongAbstract:Objective To report on 30-day adverse event rates and timing of complications following Adrenal Surgery; further, to investigate the impact of specialty (general Surgery vs urology) on these outcomes using a large prospective multi-institutional data registry. Materials and Methods Within the American College of Surgeons National Surgical Quality Improvement Program (2005-2012), patients undergoing Adrenalectomy were identified (CPT-codes: 60540, 60545, 60650). Outcomes evaluated included complications, blood transfusion, length of stay, reintervention, readmission, and mortality. Complications were further evaluated in relation to discharge status (pre-/postdischarge). Multivariable regression models assessed association between specialty and 30-day morbidity/mortality. Results During the study period, 4844 patients underwent Adrenalectomy (95.7% general Surgery). The overall complication rate was 7.5% (n = 363); 43.2% of the complications occurred postdischarge with a substantial proportion of major complications, including cardiac, pulmonary, renal, neurologic, septic, and deep venous thrombosis/pulmonary embolism also occurring postdischarge (29.9%). The overall blood transfusion, reintervention, readmission, and mortality rates were 3.9%, 2.0%, 6.4%, and 0.6%, respectively. In adjusted analyses, specialty did not have an effect on any of the outcomes ( P > .05 all). Conclusion One in 13 patients suffers a complication postAdrenalectomy. Approximately 40% of these complications occur postdischarge, primarily within the first 2 weeks of Surgery. Accurate knowledge regarding 30-day adverse event rates and timing of complications that this study provides may facilitate improved patient-physician communication and encourage early patient follow-up in this critical window. Lastly, specialty does not seem to affect outcomes in American College of Surgeons National Surgical Quality Improvement Program participant hospitals.
Martin Reincke - One of the best experts on this subject based on the ideXlab platform.
-
Adrenal Surgery for cushing s syndrome an update
Endocrinology and Metabolism Clinics of North America, 2018Co-Authors: Guido Di Dalmazi, Martin ReinckeAbstract:Recent advances in the molecular pathogenesis and the natural history of Cushing's syndrome have improved the understanding of the management of this disease. The long-term efficacy of several cortisol-lowering medical treatments is currently under evaluation. However, Adrenalectomy is a safe option for the treatment of patients affected by Cushing's syndrome. Unilateral Adrenalectomy is the gold standard for treatment of adrenocortical adenomas associated with hypercortisolism. Bilateral Adrenalectomy has been widely used in the past as definitive treatment of bilateral macronodular hyperplasia and persistent or recurrent Cushing's disease. The indication and the potential applications of this technique have been recently critically analyzed.
-
Adrenal sparing Surgery for phaeochromocytoma
British Journal of Surgery, 2003Co-Authors: Hartmut P H Neumann, Martin Reincke, Bernhard U Bender, S Eggstein, Jorg Laubenberger, Gunter KirsteAbstract:Background: Adrenalectomy is the current treatment for phaeochromocytoma. Consequently, patients with bilateral Adrenal phaeochromocytoma become steroid dependent. An Adrenal-sparing surgical technique was introduced in 1985. The results of this treatment have been reviewed. Methods: Since 1985, 39 patients with Adrenal phaeochromocytoma (16 men and 23 women, aged 10–76 years) have been treated. Thirty-three patients had unilateral and six had bilateral phaeochromocytomas. Seven of the former 33 had a contralateral Adrenal tumour resected previously. All 39 patients were re-evaluated biochemically and clinically for ipsilateral recurrence. Results: Adrenal-sparing Surgery was performed successfully in 37 of the 39 patients. In one, Adrenal-sparing resection was impossible anatomically and total Adrenalectomy was necessary. Another patient with bilateral tumours had retroperitoneal haemorrhage and became steroid dependent. None of the remaining 12 patients who had bilateral Adrenal Surgery required steroid replacement. Adrenocortical function was normal in eight and mildly impaired in two of the ten patients who had evaluation by adrenocorticotrophic hormone stimulation. After a mean follow-up of 73 months, one patient with von Hippel–Lindau disease developed a recurrence in the ipsilateral Adrenal gland. Genetic testing revealed that 26 of the 39 patients, including half of those with a unilateral tumour, had hereditary phaeochromocytoma. Conclusion: Adrenal-sparing Surgery is safe and effective, and may become the treatment of choice in patients with hereditary phaeochromocytoma. © 1999 British Journal of Surgery Society Ltd
Jesse D Sammon - One of the best experts on this subject based on the ideXlab platform.
-
adverse event rates timing of complications and the impact of specialty on outcomes following Adrenal Surgery an analysis of 30 day outcome data from the american college of surgeons national surgical quality improvement program acs nsqip
Urology, 2016Co-Authors: Akshay Sood, Kaustav Majumder, Naveen Kachroo, Jesse D Sammon, Firas Abdollah, Marianne Schmid, Linda Hsu, Wooju JeongAbstract:Objective To report on 30-day adverse event rates and timing of complications following Adrenal Surgery; further, to investigate the impact of specialty (general Surgery vs urology) on these outcomes using a large prospective multi-institutional data registry. Materials and Methods Within the American College of Surgeons National Surgical Quality Improvement Program (2005-2012), patients undergoing Adrenalectomy were identified (CPT-codes: 60540, 60545, 60650). Outcomes evaluated included complications, blood transfusion, length of stay, reintervention, readmission, and mortality. Complications were further evaluated in relation to discharge status (pre-/postdischarge). Multivariable regression models assessed association between specialty and 30-day morbidity/mortality. Results During the study period, 4844 patients underwent Adrenalectomy (95.7% general Surgery). The overall complication rate was 7.5% (n = 363); 43.2% of the complications occurred postdischarge with a substantial proportion of major complications, including cardiac, pulmonary, renal, neurologic, septic, and deep venous thrombosis/pulmonary embolism also occurring postdischarge (29.9%). The overall blood transfusion, reintervention, readmission, and mortality rates were 3.9%, 2.0%, 6.4%, and 0.6%, respectively. In adjusted analyses, specialty did not have an effect on any of the outcomes ( P > .05 all). Conclusion One in 13 patients suffers a complication postAdrenalectomy. Approximately 40% of these complications occur postdischarge, primarily within the first 2 weeks of Surgery. Accurate knowledge regarding 30-day adverse event rates and timing of complications that this study provides may facilitate improved patient-physician communication and encourage early patient follow-up in this critical window. Lastly, specialty does not seem to affect outcomes in American College of Surgeons National Surgical Quality Improvement Program participant hospitals.